Genetic Heterogeneity in Breast Cancer Susceptibility

References

• Lynch H. T., Albano W. A., Danes S., et al. Genetic predisposition to breast cancer. Cancer 1984; 53: 612–22
   PubMedGoogle Scholar
• Lynch H. T., Watson P., Conway T., Fitzsimmons S. L., Lynch J. Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 1988; 11: 263–7
   PubMedGoogle Scholar
• Hodgson S. V., Maher E. R. Genetics of human cancers by site of origin. Reproductive system. Breast. A practical guide to human cancer genetics. Cambridge University Press, Cambridge 1993; 58–63
   Google Scholar
• Ponder B. A. J. Inherited predisposition to cancer. Trends Genet 1990; 6: 213–8
   PubMed Web of Science ®Google Scholar
• Hall J. M., Lee M. K., Newman B., Morrow J. E., Anderson L. A., King M-C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684–9
   PubMed Web of Science ®Google Scholar
• Narod S., Feunteun J., Lynch H. T., et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 1991; 338: 82–3
   PubMed Web of Science ®Google Scholar
• Hall J. M., Friedman L., Guenther C., et al. Closing in on the breast cancer gene on chromosome 17q. Am J Hum Genet 1992; 50: 1235–42
   PubMed Web of Science ®Google Scholar
• Easton D. F., Bishop D. T., Ford D., Crockford G. P. Genetic linkage analysis in familial breast and ovarian cancer-results from 214 families. Am J Hum Genet 1993; 52: 678–701
   PubMed Web of Science ®Google Scholar
• Easton D. F., Ford D., Bishop D. T. the breast cancer linkage consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995; 56: 265–71
   PubMed Web of Science ®Google Scholar
• Stratton M. R., Ford D., Neuhausen S., et al. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nature Genet 1994; 7: 103–7
   PubMed Web of Science ®Google Scholar
• Miki Y., Swensen J., Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66–71
   PubMed Web of Science ®Google Scholar
• Futreal P. A., Liu Q., Shattuck-Eidens D., et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120–2
   PubMed Web of Science ®Google Scholar
• Wooster R., Neuhausen S. L., Mangion J., et al. Localization of a breast cancer susceptibility gene, BRCA2 to chromosome 13q12–13. Science 1994; 265: 2088–90
   PubMed Web of Science ®Google Scholar
• Schott D. R., Chang J. N., Deng G., et al. A candidate tumour suppressor gene in human breast cancers. Cancer Res 1994; 54: 1393–6
   PubMedGoogle Scholar
• Donehower L. A., Bradley A. The tumour suppressor p53. Biochim Biophys Acta 1993; 1155: 181–205
   PubMed Web of Science ®Google Scholar
• Harris C. C., Hollstein M. Clinical implications of the p53. tumorsuppressor gene. New Engl J Med 1993; 329: 1318–27
   PubMed Web of Science ®Google Scholar
• Li F. P., Fraumeni JF, Jr, Mulvihill J. J., et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988; 48: 5358–62
   PubMed Web of Science ®Google Scholar
• Malkin D., Li F. P., Strong L. C., Fraumeni JF, Jr, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233–8
   PubMed Web of Science ®Google Scholar
• Srivastava S., Zou Z., Pirollo K., Blattner W., Chang E. H. Germ line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990; 348: 747–9
   PubMed Web of Science ®Google Scholar
• Birch J. M., Hartley A. L., Tricker K. J., et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994; 54: 1298–1304
   PubMed Web of Science ®Google Scholar
• Børresen A-L, Andersen T. I., Garber J., et al. Screening for germ-line TP53 mutations in breast cancer patients. Cancer Res 1992; 52: 3234–6
   PubMedGoogle Scholar
• Prosser J., Porter D., Coles C., et al. Constitutional p53 mutation in a non-Li-Fraumeni cancer family. Br J Cancer 1992; 65: 527–8
   PubMedGoogle Scholar
• Sideransky D., Tokino T., Helzisouer K., et al. Inherited p53 gene mutations in breast cancer. Cancer Res 1992; 52: 2984–6
   PubMedGoogle Scholar
• Eeles R., Warren W., Knee G., et al. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and imniunohistochemical findings. Oncogene 1993; 8: 1269–76
   PubMed Web of Science ®Google Scholar
• Jolly K. W., Malkin D., Douglass E. C., Brown T. F., Sinclair A. E., Look A. T. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene 1994; 9: 97–102
   PubMed Web of Science ®Google Scholar
• Wooster R., Mangion J., Eeles R., et al. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 1992; 2: 132–4
   PubMed Web of Science ®Google Scholar
• Lobaccaro J-M, Lumbroso S., Belon C., et al. Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 1993; 11: 1799–1802
   Google Scholar
• Swift M., Morrell D., Massey R. B., Chase C. L. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991; 325: 1831–6
   PubMed Web of Science ®Google Scholar
• Børresen A-L, Andersen T. I., Tretli S., Heiberg A., Møller P. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chrom Cancer 1990; 2: 339–40
   PubMed Web of Science ®Google Scholar
• Lange E., Børresen A-L, Chen X., et al. Localization of an A-T gene to a 750 kb interval on chromosome 11q23.1 by linkage analysis of 176 families in an international consortium. Am J Hum Genet 1995; 57: 112–9
   PubMedGoogle Scholar
• Menasce L. P., White G. R. M., Harrison C. J., Boyle J. M. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and simple post-FISH banding technique. Genomics 1993; 17: 263–5
   PubMed Web of Science ®Google Scholar
• Zuppan P., Hall J. M., Lee M. K., Ponglikitmongkol M., King M-C. Possible linkage of the estrogen receptor gene to breast cancer in a familyy with late-onset disease. Am J Hum Genet 1991; 48: 1065–8
   PubMedGoogle Scholar
• Andersen T. I., Heimdal K. R., Skrede M., Tveit K., Berg K., Børresen A-L. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 1994; 94: 665–70
   PubMed Web of Science ®Google Scholar
• Lehrer S., Levine E., Savoretti P., et al. Oestrogen and progesterone receptor dissociation and family history of breast cancer. Lancet 1992; 339: 1108–9
   PubMedGoogle Scholar
• Sobol H., Birnbaum D., Eisinger F. Evidence for a third breast-cancer susceptibility gene. Lancet 1994; 344: 1151–2
   PubMedGoogle Scholar